BAALC and acute myeloid leukemia: Only one recently published manuscript analyzed the data of 71 AML patients from The Cancer Genome Atlas (TCGA) and suggested no prognostic impact of BAALC expression levels at diagnosis in patients receiving allogeneic HSCT [20].